The CGIBD Gnotobiotic Animal Core is a highly visible resource that provides CGIBD members with germ-free (sterile) and selectively colonized mice to precisely study host/environmental interactions. This world-class facility has allowed CGIBD members, their trainees and collaborators to perform cutting edge investigations in wild type and genetically engineered gnotobiotic mice in the absence of microbiota (germfree) or colonized with single bacterial species (parent strains and gene deletion/complemented mutants), defined groups of murine or human bacterial species or complex communities of commensal microbiota from human or experimental mice or humans (humanized mice) with dysbiosis to study disease pathogenesis. In the past 4 years, the combined core facilities at UNC-Chapel Hill and North Carolina State University College of Veterinary Medicine have provided 3,479 germ-free or gnotobiotic mice to 19 CGIBD members and 41 external scientists in the U.S. Approximately 70% of these mice have been used by CGIBD members. Our repertoire of gnotobiotic mice has expanded from approximately 6 strains at the last renewal to 29 strains that include wild t3T)e, knockout, transgenic and reporter mice. The Core's specific aims for renewal funding are: 1) provide germ-free (GF) or selectively colonized (gnotobiotic) wild type and mutant mice, their tissues and cells for CGIBD interdisciplinary investigators exploring host/environmental interactions; 2) Derive additional GF genetically engineered mouse strains for CGIBD investigators; 3) Provide technical assistance for CGIBD investigators; and 4) Provide limited gnotobiotic animals and tissues to unfunded new or established investigators with novel hypotheses to generate preliminary data for NIH or foundation grant applications.

Public Health Relevance

The Gnotobiotic Animal Core provides resources for CGIBD members and external investigators to study mechanisms of host/microbial interactions by precisely manipulating the commensal enteric microbiota. Investigators can compare host responses and microbial interactions in mice that are germ free (sterile), monoassociated (single microbial species), colonized with defined groups of bacterial, fungal or viral species or transplanted with of complex groups of microbiota from various phenotypes of mice or humans, for example, control or inflamed hosts. Results of these studies can identify microbial and host elements that mediate host protection, epithelial and immune development, inflammation, infection, neoplasia and recovery from injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034987-34
Application #
9605033
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
2020-03-14
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
34
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Rolston, Vineet S; Boroujerdi, Laleh; Long, Millie D et al. (2018) The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study. Inflamm Bowel Dis 24:387-393
Eaton, Kathryn; Pirani, Ali; Snitkin, Evan S et al. (2018) Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota. Elife 7:
Dong, Jing; Levine, David M; Buas, Matthew F et al. (2018) Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol 16:1598-1606.e4
Truax, Agnieszka D; Chen, Liang; Tam, Jason W et al. (2018) The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis. Cell Host Microbe 24:364-378.e6
Palacios, Michelle; Miner, Taryn A; Frederick, Daniel R et al. (2018) Identification of Two Regulators of Virulence That Are Conserved in Klebsiella pneumoniae Classical and Hypervirulent Strains. MBio 9:
Williamson, Ian A; Arnold, Jason W; Samsa, Leigh Ann et al. (2018) A High-Throughput Organoid Microinjection Platform to Study Gastrointestinal Microbiota and Luminal Physiology. Cell Mol Gastroenterol Hepatol 6:301-319
Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745
Evon, Donna M; Golin, Carol E; Ruffin, Rachel et al. (2018) Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. Pilot Feasibility Stud 4:92
Busch, Evan L; Don, Prabhani Kuruppumullage; Chu, Haitao et al. (2018) Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors. BMC Cancer 18:82
Herfarth, Hans; Barnes, Edward L; Valentine, John F et al. (2018) Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis. Gastroenterology 155:1098-1108.e9

Showing the most recent 10 out of 944 publications